EOS imaging: 2014 Financial Calendar

Regulatory News:

EOS Imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, announced its financial reporting schedule for 2014 today.

Financial publications will be released after market close. This schedule is indicative and subject to change.

• 2013 Full-year sales Wednesday January 22, 2014
• 2013 Full-year results Tuesday April 8, 2014
• 2014 First-quarter sales Tuesday April 29, 2014
• 2014 First-half sales Tuesday July 22, 2014
• 2014 First-half results Monday September 1, 2014
• 2014 Third-quarter sales Wednesday October 22, 2014

For further information about the Company or EOS®, the first full-body, low dose 2D/3D imaging system, please visit www.eos-imaging.com.

About EOS imaging:

EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market the system in 31 countries, including the United States (FDA), Japan, Canada, Australia and the European Union (EU). Backed by an installed base of 75 sites and more than 400,000 imaging sessions, EOS® benefits from worldwide recognition within the global medical community. As of December 31, 2012 the Group posted 2012 consolidated revenue of €9.42 million and employs 70 people including an R&D team of 25 engineers. The Group is based in Paris and holds three subsidiaries in Cambridge (Massachusetts), in Canada at Montreal and in Germany, and offices in Singapore. For further information, please visit www.eos-imaging.com

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

Next press release: Annual results 2013 on January 22, 2014 (after market).